Auspex Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel medicines for the treatment of orphan diseases. The company's pipeline includes product candidates to address unmet medical needs in hyperkinetic movement disorders, such as chorea associated with Huntington’s disease, tardive dyskinesia, and Tourette syndrome, as well as other orphan indications.

Guangxi Jiufu Biotechnology Co., Ltd., established on 2015-12-11, Business scope includes technology development of biotechnology,technology R & D,Technical Services,technical consulting,technology transfer;Sales of native Chinese herbal medicines.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France.

The Kobayashi Pharmaceutical Group provides a variety of products in fields such as pharmaceuticals, fragrances, dietary supplements and daily necessities. Providing products in these diverse fields is a business activity based on the broader management philosophy of “Providing Great Pleasure to People and Society” regardless of the current business domain. The current management philosophy was newly created in April 1999 by adding the meanings of “creation and innovation” and “Something New Something Different”, which are one of the characteristics of the Kobayashi Pharmaceutical Group, to the conventional management philosophy. is. The Kobayashi Pharmaceutical Group believes that pursuing the provision of “Pleasure” for people and society in this management philosophy is the significance of the Kobayashi Pharmaceutical Group.

Taiho Pharmaceutical Co., Ltd. is engaged in the research, development, production, distribution, and marketing of pharmaceutical products. The company develops drugs primarily in the area of oncology. It also develops other pharmaceuticals, controlled medical devices, designated quasi-drugs, second-class OTC drugs, designated second-class OTC drugs, and third-class OTC drugs; S-1 for the treatment of gastric cancer; TAS-102 for the treatment of colorectal cancer; and anticancer agents for oncologists, other medical care professionals, and patients. In addition, it engages in the research and development in the areas of oncology,

Quantium Medical SL, part of Else Kr��ner-Fresenius-Stiftung, is a Spanish company that manufactures medical and surgical equipment.

SSP Co., Ltd. engages in the manufacture and sale of pharmaceuticals, quasi-drugs and cosmetics. The company was founded in 1765 and is headquartered in Tokyo, Japan.

Daiichi Sankyo Healthcare Co., Ltd. engages manufacture and sale of pharmaceutical products. It produces and supplies over-the-counter drugs, quasi drugs, cosmetics, medical equipment, food, and beverages. The company was founded on December 16, 2005 and is headquartered in Tokyo, Japan.

Neurim Pharmaceuticals Ltd. is a neuroscience drug discovery and development company. The company provides Circadin, a prolonged release melatonin for insomnia. Its products include orlogin, for circadian rhythm disorders; Neu-120, which has been developed as adjunct therapy to levodopa in patients with motor fluctuations; Neu-P11, a melatonin agonist binds with high affinity to melatonin receptors; and Neu-105 for the treatment of asthma. The company was founded in 1991 by Nava Zisapel and Yehuda Zisapel and is headquartered in Tel-Aviv, Israel.

Korea Food Research Institute is a global food R&D institution that contributes to the health of Korea.

Zhejiang Weikang Pharmaceutical produces and sells pharmaceutical products, including western medications like roxithromycin soft capsules, patent medications like dropping pills, motherwort soft capsules, motherwort dispersible tablets, guci capsules, and dispersible tablets. With medication dispersible tablets, medicine soft capsules, and medicine dripping pills as the bodies and each developing its own industrial advantages, capsules, tablets, granules, soft capsules, and pills have gradually created a product structure.

Nissui Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of culture media and diagnostic reagents for medical institutions, research organizations, and food industries. It operates through the Clinical Diagnostics and Pharmaceuticals segment. The Clinical Diagnostics segment provides reagents and instruments for microbiological and immunological tests. The Pharmaceuticals segment offers over-the-counter pharmaceutical products and health food supplements. The company was founded on April 6, 1935 and is headquartered in Tokyo, Japan.

Jinli Oils & Fats Suzhou Co. Ltd. is a Chinese private company located in Suzhou. The firm operates vegetable oil mills.

Guizhou Dalong Pharmaceutical Co., Ltd., established on 1994-11-09, Business scope includes legal,regulations,Those prohibited by the State Council's decision shall not operate;law,regulations,The State Council has decided to allow(approval)of,After approval by the examination and approval authority(approval)file management;law,regulations,The State Council has decided that a license is not required(approval)of,Market entities independently choose to operate.(General project:hard capsule,Granule production;Planting of Chinese herbal medicines,buy,processing,Sales;Sales of products produced by the enterprise approved by the license;Manage the export business of the company's self-produced products and technologies;Raw and auxiliary materials needed to run the business,Instrumentation,Equipment,Import business of spare parts and technology(Except for goods and technologies that are restricted by the state to operate by the company and prohibited by the state from import and export);Enterprises can follow national regulations,Import and export business by way of trade;Health food production;food sales;Healthy food(prepackaged)Sales;Cosmetic production;Cosmetics Wholesale;Cosmetics Retail;Medical beauty service;Maternal and infant life care(Does not include medical services);pharmaceutical production;Pharmaceutical commissioned production(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations))

Wuhan Mingshi Biomedical Technology Co., Ltd., founded in 2000 by Dr. Tan Yunliang, is located in Optics Valley Biological City, Wuhan National Biological Industry Base, Hubei Province. Wuhan Mingshi Production Base covers an area of more than 60 mu, integrating scientific research and development, marketing administration, production and living, logistics and transportation, and is committed to the research, development, promotion and application of biotechnology, Chinese and Western new drugs, health food, and medical devices. Since its establishment, Mingshi Company has always adhered to the enterprise philosophy of "self-regulation by name, benefit people", taken public health as its own responsibility, and adhered to the technological development idea of "integrating traditional Chinese medicine and innovating modern biotechnology". In line with the policy of "science and technology as the guide, product research and development and market operation are equally important", a famous and real high-level senior medical research and development team consisting mainly of overseas medical doctors and masters led by Dr. Tan Yunliang has successively developed 30 categories, more than 50 products and more than 100 specifications. There are more than 30 medical and health care products with independent intellectual property rights, including Jinxinbao, Jinfubao, Jintangbao, Bei'ao capsule, Beiting capsule, Yangyan Tianyun capsule, Tiantianchangjiaerli tablet, far-infrared patch, infrared pain relief patch, Orola medical dressing women's gel, etc. Nearly 30 patents have been applied, nearly 20 national patents have been approved, and more than 60 trademarks have been applied, nearly 30 of which have been approved. The research projects also include several national drug approval, national food health, and national three categories of medical device products. Mingshi brand products have independent intellectual property rights and national patents, and have won many honorary titles such as "Famous Trademark of Hubei Province", "Excellent Product Award of the 18th China International Health Expo", "Quality Brand of the National Biological Preparation Industry", and "Products Stable and Qualified in National Quality Inspection". In order to realize the strategic idea of sustainable development, Mingshi Pharmaceutical has successively cooperated with some domestic first-class enterprises and institutions, and has continuously increased investment in R&D and production. In 2001, Wuhan Jianmin Pharmaceutical Science and Technology Development Co., Ltd. was established in cooperation with Wuhan Jianmin Pharmaceutical Group, realizing the strong combination of product research and development; In 2002, invested in Wuhan Jianmin Pharmaceutical Group New Century Pharmaceutical Co., Ltd. (now renamed as Wuhan Jianhua New Century Pharmaceutical Co., Ltd., a GSP certified enterprise); In 2005, he participated in the establishment of Guangzhou Zhaohe Health Technology Co., Ltd. In order to continuously improve its scientific research strength, Mingshi Pharmaceuticals has actively cooperated with Huazhong University of Science and Technology, Hubei University of Traditional Chinese Medicine, Wuhan University and other scientific research institutions to carry out extensive foreign exchanges and cooperation, and constantly introduced and trained medical professionals. In terms of the external environment, in recent years, with the development of the national economy, China's per capita disposable income has continued to increase, the health awareness of Chinese people has increased, the market size and sales of medical and health products have increased year by year, and the country has gradually strengthened the improvement and supervision of laws and regulations on medical and health products; From the company's internal perspective, Mingshi Pharmaceutical's R&D capability, production quality, marketing team, land administration relationship and various management systems are becoming more and more perfect, and it has all kinds of software and hardware conditions to become bigger and stronger in the domestic medical and health care product market. This also strengthened the confidence of real people!

Shanghai Jianlian Biotechnology Co., Ltd., established on 2002-04-27, Business scope includes biotechnology(transgenic technology,Except human stem cell genetic diagnosis)technology development in the field,technical consulting,Technical Services,technology transfer.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Manufactures pharmaceuticals for cardiovascular treatment, central nervous system, internal medicine drugs and oncology treatment

Yulin Yushen Industrial Zone Yuhuang Bio-Pharmaceutical Co., Ltd., established on 2013-08-16, Business scope includes western medicine,Western medicine raw materials,Chinese patent medicine,biochemical agent,Research and development of health products and technology transfer(prepare to build).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)